MO - Altria Group, Inc.

NYSE - NYSE Delayed Price. Currency in USD
42.01
-1.61 (-3.69%)
At close: 4:02PM EDT
Stock chart is not supported by your current browser
Previous Close43.62
Open43.44
Bid0.00 x 4000
Ask0.00 x 1800
Day's Range41.97 - 43.51
52 Week Range41.97 - 66.04
Volume20,736,637
Avg. Volume9,700,020
Market Cap78.479B
Beta (3Y Monthly)0.38
PE Ratio (TTM)12.54
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & Yield3.36 (7.56%)
Ex-Dividend Date2019-09-13
1y Target EstN/A
Trade prices are not sourced from all markets
  • Altria Falls 3%
    Investing.com

    Altria Falls 3%

    Investing.com - Altria (NYSE:MO) fell by 3.16% to trade at $42.24 by 13:02 (17:02 GMT) on Friday on the NYSE exchange.

  • Implied Volatility Surging for Altria (MO) Stock Options
    Zacks

    Implied Volatility Surging for Altria (MO) Stock Options

    Investors need to pay close attention to Altria (MO) stock based on the movements in the options market lately.

  • Cannabis Industry Heats Up, Trump Might Ban Vaping
    Market Realist

    Cannabis Industry Heats Up, Trump Might Ban Vaping

    Cannabis legalization is heating up. More states are coming forward to legalize marijuana. Cannabis is also gaining global popularity.

  • Philip Morris (PM) Hikes Dividend to Boost Shareholders Value
    Zacks

    Philip Morris (PM) Hikes Dividend to Boost Shareholders Value

    Philip Morris (PM) is consistently boosting shareholders' value via dividend payouts. The company announces dividend hike of 2.6%.

  • Trump May Ban Flavored E-Cigarettes: Who Wins, Who Loses
    Zacks

    Trump May Ban Flavored E-Cigarettes: Who Wins, Who Loses

    Vaping is a growing trend among youngsters, but Trump's recent threat to ban flavored e-cigarettes raises questions. Will traditional cigarette get back its lost glory?

  • 'Deep pockets': Lawmaker on why Congress, Trump administration haven't acted to curb vaping
    Yahoo Finance

    'Deep pockets': Lawmaker on why Congress, Trump administration haven't acted to curb vaping

    The Trump administration is moving to ban flavored e-cigarettes, but one lawmaker says Trump has not acted quickly enough to combat the risks posed by vaping.

  • Altria (MO) Outpaces Stock Market Gains: What You Should Know
    Zacks

    Altria (MO) Outpaces Stock Market Gains: What You Should Know

    Altria (MO) closed at $44.71 in the latest trading session, marking a +1.06% move from the prior day.

  • Investing.com

    NewsBreak: Trump Says He's Looking Into Banning Non-Tobacco Vaping Products

    Investing.com – President Donald Trump said Wednesday he was looking into banning all non-tobacco flavored vaping products from the market. He made the comment to reporters at the White House.

  • Buy Aurora Cannabis (ACB) Stock Before Earnings, Despite Marijuana Volatility?
    Zacks

    Buy Aurora Cannabis (ACB) Stock Before Earnings, Despite Marijuana Volatility?

    Despite growing sales and wider legalization, many pot stocks have been insanely volatile as Wall Street and investors try to wrap their heads around the marijuana industry. So should you think about buying "cheap" Aurora Cannabis (ACB) Stock before Q4 earnings?

  • Juul’s Marketing of Device May Have Violated Law, FDA Says
    Bloomberg

    Juul’s Marketing of Device May Have Violated Law, FDA Says

    (Bloomberg) -- Juul Labs Inc. was warned by U.S. health officials that it may have violated the law by making claims its e-cigarette devices are safe. The letter increases pressure on the richly valued company at the same time a mysterious lung ailment is raising new questions about the health effects of vaping.The Food and Drug Administration sent Juul a warning letter on Monday that said the agency had determined that the company has marketed its products as less risky than cigarettes without gaining the agency’s approval. Juul has pitched its sleek, USB-like vaping device as a way for adults to quit smoking -- though the FDA said that the company also targeted students.The reprimand could foreshadow a tough road for Juul’s efforts to gain FDA clearance to continue selling its products, which all e-cigarette makers must do starting next year. The industry is under mounting scrutiny due to a surge in teenage vaping and recent deaths that public-health officials have connected to inhaling vapor from e-cigarettes.The FDA also sent Juul a letter requesting documents related to the company’s advertising and promotional efforts, given that its vape devices “continue to represent a significant proportion of the overall use” of e-cigarettes by children. Juul halted much of its social-media marketing last year after criticism that its stylish ads on Instagram and other apps targeted younger users.“Juul has ignored the law, and, very concerningly, has made some of these statements in school to our nation’s youth,” said Acting FDA Commissioner Ned Sharpless.“We are reviewing the letters and will fully cooperate,” Ted Kwong, a Juul spokesman, said.Nationwide ProbesFederal and state health officials are investigating a number of mysterious deaths from illnesses that have been connected to use of vaping devices. The Centers for Disease Control and Prevention said on Friday it was investigating 450 cases of the ailment nationwide. Five people have died from the illness, the CDC says.In addition, the FDA has been looking into whether e-cigarettes are linked to seizures after receiving initial reports from Juul users. The investigation has widened into 127 reports of seizures linked to various types of e-cigarettes.Representative Raja Krishnamoorthi, an Illinois Democrat, wrote Sharpless last week urging the agency to look into the claims Juul has made, including some before his House Oversight and Reform subcommittee. During a subcommittee hearing in July, Krishnamoorthi’s staff revealed that a Juul representative had told students that the company’s device “was much safer than cigarettes” and called the products “totally safe.” The FDA highlighted those statements Monday.The FDA told Juul that parts of its “Make the Switch” marketing campaign that encourages smokers to use its device convey that they’re safer than cigarettes. The agency asked Juul for any consumer-perception studies related to whether Juul’s representation implies the products are smoking-cessation devices. The FDA hasn’t approved any of the company’s products as smoking-cessation tools.Last week, Juul spokesman Ted Kwong disputed that the marketing was violating FDA rules.“Switching is not another word for cessation,” Kwong said. “They mean two very different things. Switching involves continuing to consume nicotine but from a different device, while cessation is about getting users to eliminate their nicotine consumption altogether. We are a switching product.”Juul is one of the most highly valued private companies in the U.S. Last year, the maker of Marlboro cigarettes, Altria Group Inc., invested nearly $13 billion in Juul, giving it a valuation at the time of roughly $35 billion. Altria shares were little-changed in New York trading Monday, trading at $43.89 at 11:36 a.m.(Updates with Juul comment in sixth paragraph.)To contact the reporter on this story: Anna Edney in Washington at aedney@bloomberg.netTo contact the editors responsible for this story: Drew Armstrong at darmstrong17@bloomberg.net, Timothy Annett, Rick SchineFor more articles like this, please visit us at bloomberg.com©2019 Bloomberg L.P.

  • Altria Group, Inc. (NYSE:MO) Pays A 1.9% In Just 4
    Simply Wall St.

    Altria Group, Inc. (NYSE:MO) Pays A 1.9% In Just 4

    Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be...

  • Motley Fool

    Juul E-Cigs Face FTC Scrutiny

    The influence of the electronic cigarette maker's marketing on teens is being investigated.

  • Three Deaths Have Been Linked to Vaping
    SAY

    Three Deaths Have Been Linked to Vaping

    Federal agencies have announced that at least three deaths have been linked to vaping, as well as 450 possible severe lung illness in 33 states. Epidemic With the increased popularity of the electronic cigarettes is coming increasing signs of its harmful effects, as the Indiana Department of Health announced today the third death from lung illnesses linked to vaping. The first case of the illness was reported in Illinois back in April. Scare At first, the lung illnesses seemed limited to a few cases, but this summer it has developed into a widespread public health crisis, as teenagers and young adults that were otherwise in normal health would enter emergency rooms with shortness of breath and flu symptoms, requiring them to immediately be placed on ventilators. The New York Times noted that “public health officials have underscored one fundamental point: that the surge in illnesses is a new phenomenon and not merely a recognition of a syndrome that may have been developing for years.” Control The Center for Disease Control is currently investigating why vaping seems to be so harmful. There’s the well-reported fact that vaping often allows the user, especially if they’ve tampered with the e-cigarette device or purchased one off the street, to consume far more nicotine in a setting than they would from smoking a cigarette. But beyond that, the CDC believes that a chemical commonly found in vaping fluid could be responsible for the lung illnesses. Dr. David C. Christiani wrote in an editorial in the New England Journal of Medicine that the fluid contains “at least six groups of potentially toxic compounds.” While the CDC continues it investigation, the federal agency has urged the public to stop vaping. Big Tobacco The popularity of vaping was a boon to the tobacco industry, which has seen the popularity of cigarettes decline precipitously over the past decade, and the industry gian Altira invested 35% in JUUL, by far the most popular e-cig brand. But while sales have been robust, this year has been filled with negative headlines and government investigations for the industry, including a Food and Drug Administration crackdown on e-cig sales, and states such as Connecticut and North Carolina looking into whether JUUL marketed itself to young people. With the news of the rise of illnesses and deaths related to vaping, don’t be surprised if government agencies take even further steps to curtail the product’s reach. -Michael Tedder Photo by Adobe

  • Is Cronos Group Ready to Make a Comeback?
    Motley Fool

    Is Cronos Group Ready to Make a Comeback?

    Cronos was once hailed as the best performing marijuana stock of all time, but how much can the pot firm grow from here?

  • 3 Pot Stocks to Avoid Like the Plague in September
    Motley Fool

    3 Pot Stocks to Avoid Like the Plague in September

    These marijuana stocks are unlikely to have investors seeing green in the near term.

  • Cronos Group Closes Lord Jones Acquisition
    Motley Fool

    Cronos Group Closes Lord Jones Acquisition

    The company puts a bow made of hemp on its $300 million CBD beauty products buy.

  • 2 of the Safest Bets in the Cannabis Industry
    Motley Fool

    2 of the Safest Bets in the Cannabis Industry

    Investing in pot stocks isn't the only way to cash in on the industry's rapid growth.

  • Altria Is Investment Royalty After 50th Straight Years of Dividend Hikes
    Motley Fool

    Altria Is Investment Royalty After 50th Straight Years of Dividend Hikes

    The tobacco giant has a track record few other businesses can match.

  • Cronos: What’s the Word on Wall Street?
    Market Realist

    Cronos: What’s the Word on Wall Street?

    Cronos Group (CRON) reported its Q2 results last month. Despite better-than-expected sales, its Q2 losses widened and its stock has fallen 23% since then.

  • It's Not Cigarettes Bringing Altria and Philip Morris International Together Again
    Motley Fool

    It's Not Cigarettes Bringing Altria and Philip Morris International Together Again

    Smoking alternatives are the future of the tobacco industry and these industry giants.

  • Altria (MO) Stock Sinks As Market Gains: What You Should Know
    Zacks

    Altria (MO) Stock Sinks As Market Gains: What You Should Know

    Altria (MO) closed the most recent trading day at $43.74, moving -1.15% from the previous trading session.

  • JUUL Is Under Fire On All Sides
    SAY

    JUUL Is Under Fire On All Sides

    The electronic cigarette kingpin JUUL has been facing heavy scrutiny this year, and now it’s about to undergo yet another investigation. But the brand’s less-than-official streetwise competition is also getting raked over the coals. Minor Threat Do you know how some sandwich shops will give you a customer appreciation card, and if you buy enough lunches there you get a free one? Well, if businesses had those, but instead of sandwiches it was government investigations into their business practices, then JUUL would definitely be due for a free one. The besieged electronic cigarette company is being investigated again, this time by the Federal Trade Commission, which is looking into whether the company marketed its product to minors. States including Connecticut and North Carolina have begun similar inquiries, but this is clearly on a whole other level. Of particular interest to the FTC is JUUL’s abandoned program of paying social media influencers to promote their product. A frequent criticism of JUUL is that its fruit flavors such as mango are designed to appeal to teenagers, and in response the company pulled the flavors from retailers, though they remain available online. The FTC is reportedly determining whether to seek monetary damages. FTC For You and Me The FTC isn’t content to let the FDA have all the fun. Last year it conducted a surprise inspection of JUUL’s headquarters and seized documents about the company’s marketing. JUUL’s first marketing campaign “Vaporized” featured images of “cool” 20 and 30s something using the product, which critics say made it attractive to teenagers. Urge to Merge This probe has apparently been underway for quite a while, but it’s coming to light as the news breaks that JUUL’s parent company Alitra is looking to reunite with Philip Morris International. JUUL has been so heavily criticized for the safety of its products in the U.S. (the Center for Disease Control is investigating a “cluster” of lung illnesses that could possibly be related to e-cigarette use) that analysts think Alitra is zeroing in on international markets. Earlier this year, a shareholder proposal for Alitra to disclose and begin reducing nicotine levels in its products failed to pass. Streetwise In other electronic cigarette news, the CDC has also warned pregnant women and young adults to avoid the e-cigarettes altogether as it continues its investigation into the vaping’s safety. -Michael Tedder Photo by Adobe

  • CDC Links THC Vaping Products to Lung Illness
    Bloomberg

    CDC Links THC Vaping Products to Lung Illness

    Sep.06 -- Sudden, serious lung illnesses that have struck people who used vaping devices have been tied in many cases to products that contain THC, the main active ingredient in marijuana, the U.S. Centers for Disease Control and Prevention said. Bloomberg's Craig Giammona has more on "Bloomberg Technology."